Semi-annual review of the VINX30 Index (20/16)


The semi-annual review of the VINX 30 Index has now been completed. As a result of the review, Genmab (GEN) will be added, whereas A.P. Moller – Maersk B (MAERSK B) will be removed from the index.

The VINX 30 Index constituents effective with the market open on Monday, June 20, 2016 are:

  

ABB Ltd Novo Nordisk B
ASSA ABLOY AB ser. B Pandora
AstraZeneca PLC Sampo Plc A
Atlas Copco AB ser. A Sandvik AB
Carlsberg A/S B Skand. Enskilda Banken ser. A
Coloplast B Statoil ASA
Danske Bank Swedbank AB ser A
DNB ASA Svenska Cellulosa AB SCA ser. B
Ericsson, Telefonab. L M ser. B Svenska Handelsbanken ser. A
Genmab Telenor ASA
Hennes & Mauritz AB, H & M ser. B Telia Company AB
Investor AB ser. B UPM-Kymmene Corporation
KONE Oyj B Vestas Wind Systems
Nokia Corporation Volvo, AB ser. B
Nordea Bank AB Yara International ASA

   

For full access to daily data on weights, proforma, free float factors, corporate actions, historical index values etc. please sign up for our Global Index Watch service at http://indexes.nasdaqomx.com/

For further information concerning this notice please contact Nasdaq Global Index Operations, telephone + 46 8 405 62 96, or e-mail indexsupport@nasdaq.com


Attachments

20_2016-06-13_VINX30_Review.pdf 20_2016-06-13_VINX30_Proforma.xls